Holen Sie sich die Stockscreener-App
9.72
9.75%
-1.05
Vorhandelsmarkt:
9.72
Schlusskurs vom Vortag:
$10.77
Offen:
$10.47
24-Stunden-Volumen:
8.75M
Relative Volume:
2.01
Marktkapitalisierung:
$4.83B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
24.30
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
-10.08%
1M Leistung:
-14.06%
6M Leistung:
-32.97%
1J Leistung:
-37.01%
1-Tages-Spanne:
$9.67
$10.50
1-Wochen-Bereich:
$9.67
$10.80
52-Wochen-Spanne:
$9.67
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
2500 INNOVATION WAY, GREENFIELD
Vergleichen Sie ELAN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
9.72 | 4.83B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
159.61 | 71.47B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.19 | 47.98B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.45 | 47.20B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.85 | 17.02B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
307.36 | 13.80B | 2.76B | 1.11B | 898.10M | 22.77 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Veterinary Clostridium Vaccine Market Detailed Industry - openPR.com
Dogs Vaccines Market Generated Opportunities, Future Scope - openPR.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com
Elanco stock hits 52-week low at $10.02 amid market challenges - Investing.com
Veterinary Oncology Market Future Business Opportunities - openPR.com
FDA Approval of Elanco Cow Ammonia Drug Upheld in Federal Court - Bloomberg Law News
ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
FDA Beats Challenge To Approval Of Elanco's Cattle Gas Drug - Law360
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Elanco wins dismissal of Tevra Brands' US antitrust complaint - MLex
Elanco Animal Health: Even Cheaper, Still Not A Buy - Seeking Alpha
Dogs Vaccines Market Size, Industry Shares, Global Growth - openPR.com
Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Shareholders to Inquire about Securities Investigation - markets.businessinsider.com
Corient Private Wealth LLC Decreases Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Is Elanco Animal Health (ELAN) About to Explode? - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect - Markets Insider
SEC Form DEFA14A filed by Elanco Animal Health Incorporated - Quantisnow
SEC Form DEF 14A filed by Elanco Animal Health Incorporated - Quantisnow
Form DEF 14A Elanco Animal Health For: May 16 - StreetInsider.com
Connor Clark & Lunn Investment Management Ltd. Invests $652,000 in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Prudential Financial Inc. Has $51.17 Million Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Is Elanco Animal Health Incorporated (ELAN) The Best Pet Stock to Buy According to Billionaires? - Insider Monkey
Elanco Animal Health Incorporated (NYSE:ELAN) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Sector Gamma AS Invests $3.35 Million in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation - Markets Insider
Cannon Global Investment Management LLC Invests $454,000 in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Fox Run Management L.L.C. Acquires New Shares in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Proficio Capital Partners LLC Makes New $405,000 Investment in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
Animal Vaccines Market Projected To Witness Substantial - openPR.com
Veterinary Antibiotics Market Detailed In New Research Report - openPR
Elanco Animal Health Incorporated (NYSE:ELAN) Stake Raised by Magnetar Financial LLC - MarketBeat
Raymond James Financial Inc. Makes New $10.56 Million Investment in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco to Participate in Upcoming Investor Conferences - GuruFocus.com
Peering Into Elanco Animal Health's Recent Short Interest - Benzinga
Veterinary Medicine Market Detailed In New Research Report 2025 | Ceva, Zoetis, Elanco, Chanelle Pharma Group - openPR
Here’s Why Elanco Animal Health Incorporated (ELAN) Declined in Q4 - MSN
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Animal Vaccines Market Future Business Opportunities - openPR
Animal Health Products Market Next Big Thing | Major Giants - openPR
Elanco Animal Health (ELAN): Among the Most Undervalued Biotech Stocks to Invest In - Yahoo Finance
Victory Capital Management Inc. Purchases 11,216 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Jones Financial Companies Lllp Boosts Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Fish Vaccine Market Growth in Future Scope 2025-2032 | Zoetis, Elanco, Virbac, HIPRA, Veterquímica S.A. - openPR
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect - Markets Insider
Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment - Yahoo Finance
Elanco Animal Health announces changes to board of directors -March 17, 2025 at 05:39 pm EDT - Marketscreener.com
Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets - PR Newswire
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Acquired by Steward Partners Investment Advisory LLC - Defense World
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):